Primary Category:
Cancer Control and Prevention Protocols, Treatment Protocols
Disease Category:
Adjuvant Breast, Breast
A Randomized Phase III Double-Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Patients previously enrolled in A011502 patients are eligible for enrollment in companion study A211601 and may be consented with A211601 Retrospective Consent.
Patients enrolling in A011502 patients must be enrolled in companion study A211601 and may be consented with A211601 Consent.
Eligible for screening study DCP 001
NCT#02927249
(Click for More Info)
Primary Category:
Cancer Control and Prevention Protocols
Disease Category:
Adjuvant Breast, Breast
Evaluation of Mammographic Breast Density Effect of Aspirin: A Companion to Alliance Study A011502
NCT#03609021
(Click for More Info)
Patients previously enrolled in A011502 are eligible to be enrolled in this protocol using the A211601 Retrospective Consent.
Eligible for screening study DCP 001
The following protocols have consent changes requiring you to reconsent active patients (unless otherwise noted below).
MCC policy requires all reconsents be completed at the patient’s next scheduled office visit or within two weeks of MCC release of approved consent document, whichever is sooner.
(Please click the links for the available highlighted reconsents & letters.)
September 15th, 2020
September 1st, 2020
- No consent changes requiring reconsents.
August 19th, 2020
August 18th, 2020
August 4th, 2020
July 21st, 2020
- No consent changes requiring reconsents.
July 7th, 2020
June 16th, 2020
June 2nd, 2020
May 19th, 2020
May 7th, 2020
- No consent changes requiring reconsents.
May 5th, 2020
- No consent changes requiring reconsents.
April 23rd, 2020
- No consent changes requiring reconsents.
April 21st, 2020
April 7th, 2020
March 17th, 2020
March 3rd, 2020
February 26th, 2020 – CIRB
February 2020 – Local IRB
- No consent changes requiring reconsents.
February 14th, 2020 – CIRB
- No consent changes requiring reconsents.
January 29th, 2020 – CIRB
- No consent changes requiring reconsents.
January 2020 – Local IRB
- No consent changes requiring reconsents.
January 15th, 2020 – CIRB
January 2nd, 2020 – CIRB
December 2019 – Local IRB
December 16th, 2019 – CIRB
December 2nd, 2019 – CIRB
November 2019 – Local IRB
- No consent changes requiring reconsents.
November 15th, 2019 – CIRB
November 1st, 2019 – CIRB
October 2019 – Local IRB
- No consent changes requiring reconsents.
October 11th, 2019 – CIRB
October 4th, 2019 – CIRB
October 1st, 2019 – CIRB
September 2019 – Local IRB
- No consent changes requiring reconsents.
September 16th, 2019 – CIRB
September 3rd, 2019 – CIRB
August 2019 – Local IRB
- No consent changes requiring reconsents.
August 15th, 2019 – CIRB
August 1st, 2019 – CIRB
July 23rd, 2019 – CIRB
July 2019 – Local IRB
July 15th, 2019 – CIRB
July 1st, 2019 – CIRB
June 2019 – Local IRB
June 14th, 2019 – CIRB
May 31st, 2019 – CIRB
May 15th, 2019 – CIRB
May 1st, 2019 – CIRB
- No consent changes requiring reconsents.
April 26th, 2019 – CIRB
April 15th, 2019 – CIRB
April 2019 – Local IRB
- No consent changes requiring reconsents.
April 1st, 2019 – CIRB
- E1910 – Pts receiving Blinatumomab ONLY
March 15th, 2019 – CIRB
March 2019 – Local IRB
- No consent changes requiring reconsents.
March 1st, 2019 – CIRB
February 2019 – Local IRB
- No consent changes requiring reconsents.
February 15th, 2019 – CIRB
February 1st, 2019 – CIRB
January 2019 – Local IRB
- No consent changes requiring reconsents.
January 15th, 2019 – CIRB
January 2nd, 2019 – CIRB
[/members_only]
